Telemedicine companies may soon become targets for mergers and acquisitions as the COVID-19 pandemic continues. As companies such as Livongo have been acquired by telemedicine giant Teladoc, other telemedicine buyers may choose to expand into similar markets such as chronic care. CEO Sebastian Seiguer explains that companies such as emocha are valuable and successful because they reach often underserved populations, noting that the platform & service benefits both patients and providers.

Read the full article in S&P Global